Venture financing deals in pharma rise in H2 2021
Still, this growth is less impressive compared to the 81.1% rise in pharma VC deals seen in H1 compared to…
By
Deals
Latest in
Deals
Revealed: emerging pharmaceutical industry investment themes to watch in 2022
Digital therapeutics and biosimilars among the fastest emerging investment themes for deals in the pharma industry in 2021
By
Robotics-related deals in the pharmaceutical industry increased in H1 2021
Robotics-related deals made up 0.6% of all deals announced in the pharma sector in H1 2021.
By
Cloud-related deals in the pharma industry increased in H1 2021
In the first six months of 2021, the total number of announced deals in the pharmaceutical sector increased by 8.6%…
By
Tracking the pharma sector’s Covid-19 recovery: how has the sector fared in Q2 2021?
The pharma sector has emerged as a relatively strong performer in the world economy when it comes to post-pandemic performance…
By
Calico and AbbVie: Google-backed partnership re-commits to anti-ageing mission
Calico entered a partnership with global biopharma AbbVie to uncover and market novel treatments for age-related diseases in 2014.
By
Adagio and Biocon collaborate to develop antibody therapy for Covid-19
Biocon will obtain data from Adagio’s EUA submissions to pursue approval for the treatment in India and other emerging markets.
Inside Philip Morris’ controversial Vectura acquisition
The tobacco company’s buyout of a healthcare business has sparked both fury and confusion from campaigners and politicians.
By